{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:05:12Z","timestamp":1784531112696,"version":"3.55.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Governo Italiano Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012352","name":"University of Milan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119708","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:40:26Z","timestamp":1782754826000},"page":"119708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Raloxifene and tamoxifen reshape the immunometabolic phenotype of TLRs-activated macrophages through AEBS inhibition and lysosomal stress"],"prefix":"10.1016","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3151-4210","authenticated-orcid":false,"given":"Chiara","family":"Sfogliarini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Bernardinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien Hong","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Antonia","family":"Corsetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Maria","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Cattani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Candida","family":"Cesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0617-0233","authenticated-orcid":false,"given":"Marcello","family":"Allegretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9498-5266","authenticated-orcid":false,"given":"Sara","family":"Della Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Locati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4351-3650","authenticated-orcid":false,"given":"Elisabetta","family":"Vegeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119708_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/or.2025.1564642","article-title":"Treating ER-positive breast cancer: a review of the current FDA-approved SERMs and SERDs and their mechanisms of action","volume":"19","author":"Kim","year":"2025","journal-title":"Oncol. Rev."},{"key":"10.1016\/j.biopha.2026.119708_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.879020","article-title":"Tamoxifen twists again: on and off-targets in macrophages and infections","volume":"13","author":"Sfogliarini","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119708_bib3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41418-021-00844-6","article-title":"Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infection","volume":"29","author":"Allegretti","year":"2022","journal-title":"Cell. Death Differ."},{"key":"10.1016\/j.biopha.2026.119708_bib4","article-title":"Selective inhibition of Ebola entry with selective estrogen receptor modulators by disrupting the endolysosomal calcium","volume":"7","author":"Fan","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2026.119708_bib5","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1089\/mdr.2016.0196","article-title":"From breast cancer to antimicrobial: combating extremely resistant gram-negative \u201cSuperbugs\u201d using novel combinations of polymyxin B with selective estrogen receptor modulators","volume":"23","author":"Hussein","year":"2017","journal-title":"Microb. Drug. Resist."},{"issue":"6","key":"10.1016\/j.biopha.2026.119708_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02272-18","article-title":"Repurposing estrogen receptor antagonists for the treatment of infectious disease","volume":"9","author":"Montoya","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.biopha.2026.119708_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101450","article-title":"A phase 2 randomized, double-blinded, placebo-controlled, multicenter trial evaluating the efficacy and safety of raloxifene for patients with mild to moderate COVID-19","volume":"48","author":"Nicastri","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10.1016\/j.biopha.2026.119708_bib8","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2309664121","article-title":"Polyphosphate kinase-1 regulates bacterial and host metabolic pathways involved in pathogenesis of Mycobacterium tuberculosis","volume":"121","author":"Chugh","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.biopha.2026.119708_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/mbo3.945","article-title":"Antimicrobial resistance: a multifaceted problem with multipronged solutions","volume":"8","author":"Gil-Gil","year":"2019","journal-title":"MicrobiologyOpen"},{"issue":"1","key":"10.1016\/j.biopha.2026.119708_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03024-22","article-title":"Repurposing tamoxifen as potential host-directed therapeutic for tuberculosis","volume":"14","author":"Boland","year":"2023","journal-title":"MBio"},{"issue":"9","key":"10.1016\/j.biopha.2026.119708_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics13090834","article-title":"Innovative strategies in drug repurposing to tackle intracellular bacterial pathogens","volume":"13","author":"Lorente-Torres","year":"2024","journal-title":"Antibiotics"},{"issue":"6","key":"10.1016\/j.biopha.2026.119708_bib12","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/jac\/dkac069","article-title":"Raloxifene prevents intracellular invasion of pathogenic bacteria through modulation of cell metabolic pathways","volume":"77","author":"Chang","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.biopha.2026.119708_bib13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/jac\/dkm219","article-title":"Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes","volume":"60","author":"Miguel","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.biopha.2026.119708_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00124-20","article-title":"Bazedoxifene suppresses intracellular mycobacterium tuberculosis growth by enhancing autophagy","volume":"5","author":"Ouyang","year":"2020","journal-title":"MSphere"},{"key":"10.1016\/j.biopha.2026.119708_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, mechanisms, and significance of macrophage plasticity","volume":"15","author":"Locati","year":"2020","journal-title":"Annu. Rev. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119708_bib16","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011247","article-title":"Toll-like receptor signaling","volume":"5","author":"Lim","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119708_bib17","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and Regulation of NLRP3 Inflammasome Activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119708_bib18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cmet.2020.05.003","article-title":"Toll-like receptors induce signal-specific reprogramming of the macrophage lipidome","volume":"32","author":"Hsieh","year":"2020","journal-title":"Cell. Metab."},{"key":"10.1016\/j.biopha.2026.119708_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1255533","article-title":"Interleukin 6: at the interface of human health and disease","volume":"14","author":"Grebenciucova","year":"2023","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119708_bib20","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.4049\/jimmunol.0901754","article-title":"Innate immunity against bacterial infection following hyperoxia exposure is impaired in NRF2-deficient mice","volume":"183","author":"Reddy","year":"2009","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119708_bib21","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1172\/JCI25790","article-title":"Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis","volume":"116","author":"Thimmulappa","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2026.119708_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112274","article-title":"ER\u03b1-independent NRF2-mediated immunoregulatory activity of tamoxifen","volume":"144","author":"Pepe","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119708_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115008","article-title":"The immune activity of selective estrogen receptor modulators is gene and macrophage subtype-specific yet converges on Il1b downregulation","volume":"165","author":"Sfogliarini","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.biopha.2026.119708_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1566524019666191014112133","article-title":"Selective estrogen receptor modulators (SERMs): mechanistic insights against microbial infections","volume":"20","author":"Garg","year":"2020","journal-title":"Curr. Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119708_bib25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12275-021-0617-7","article-title":"Raloxifene as a treatment option for viral infections","volume":"59","author":"Hong","year":"2021","journal-title":"J. Microbiol."},{"key":"10.1016\/j.biopha.2026.119708_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116544","article-title":"AEBS inhibition in macrophages: augmenting reality for SERMs repurposing against infections","volume":"229","author":"Sfogliarini","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119708_bib27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41423-021-00827-0","article-title":"Reprogramming cholesterol metabolism in macrophages and its role in host defense against cholesterol-dependent cytolysins","volume":"19","author":"Lee","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119708_bib28","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.tcb.2020.09.006","article-title":"Lipid metabolism in regulation of macrophage functions","volume":"30","author":"Yan","year":"2020","journal-title":"Trends Cell. Biol."},{"key":"10.1016\/j.biopha.2026.119708_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00167","article-title":"Cathepsin B is required for NLRP3 inflammasome activation in macrophages, through NLRP3 interaction","volume":"8","author":"Chevriaux","year":"2020","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.biopha.2026.119708_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1559125","article-title":"Lysosome-associated CASM: from upstream triggers to downstream effector mechanisms","volume":"13","author":"Kaur","year":"2025","journal-title":"Front. Cell. Dev. Biol."},{"issue":"13","key":"10.1016\/j.biopha.2026.119708_bib31","doi-asserted-by":"crossref","first-page":"9158","DOI":"10.1074\/jbc.M113.531202","article-title":"Lysosomes integrate metabolic-inflammatory cross-talk in primary macrophage inflammasome activation","volume":"289","author":"Weber","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119708_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056265","article-title":"Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection","volume":"8","author":"Shoemaker","year":"2013","journal-title":"PloS. One"},{"issue":"2","key":"10.1016\/j.biopha.2026.119708_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/0976-500X.72351","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"1","author":"Kilkenny","year":"2010","journal-title":"J. Pharmacol. Pharmacother."},{"issue":"19","key":"10.1016\/j.biopha.2026.119708_bib34","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1242\/dev.127.19.4277","article-title":"Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes","volume":"127","author":"Dupont","year":"2000","journal-title":"Development"},{"key":"10.1016\/j.biopha.2026.119708_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/srep44270","article-title":"Self-renewal and phenotypic conversion are the main physiological responses of macrophages to the endogenous estrogen surge","volume":"7","author":"Pepe","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119708_bib36","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bph.14153","article-title":"Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers","volume":"175","author":"Curtis","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119708_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11624","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.biopha.2026.119708_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.638","article-title":"Reciprocal interference between the NRF2 and LPS signaling pathways on the immune-metabolic phenotype of peritoneal macrophages","volume":"8","author":"Mornata","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"issue":"3","key":"10.1016\/j.biopha.2026.119708_bib39","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ijpddr.2018.10.007","article-title":"Tamoxifen inhibits the biosynthesis of inositolphosphorylceramide in Leishmania","volume":"8","author":"Trinconi","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug. Resist."},{"issue":"5","key":"10.1016\/j.biopha.2026.119708_bib40","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/jac\/dkv495","article-title":"Efficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis","volume":"71","author":"Trinconi","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2026.119708_bib41","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev-physiol-022516-034348","article-title":"Macrophages and the recovery from acute and chronic inflammation","volume":"79","author":"Hamidzadeh","year":"2017","journal-title":"Annu. Rev. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119708_bib42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.biopha.2026.119708_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00299-20","article-title":"Critical determinants of cytokine storm and type I interferon response in COVID-19 pathogenesis","volume":"34","author":"Ramasamy","year":"2021","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2026.119708_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005581","article-title":"Sulforaphane Inhibits HIV Infection of Macrophages through Nrf2","volume":"12","author":"Furuya","year":"2016","journal-title":"PLoS. Pathog."},{"issue":"6","key":"10.1016\/j.biopha.2026.119708_bib45","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1164\/rccm.201705-0903OC","article-title":"Opsonic phagocytosis in chronic obstructive pulmonary disease is enhanced by Nrf2 agonists","volume":"198","author":"Bewley","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"78","key":"10.1016\/j.biopha.2026.119708_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002042","article-title":"Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model","volume":"3","author":"Harvey","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.biopha.2026.119708_bib47","article-title":"NRF2 in Viral Infection","volume":"10","author":"Herengt","year":"2021","journal-title":"Antioxid. (Basel Switz. )"},{"key":"10.1016\/j.biopha.2026.119708_bib48","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.freeradbiomed.2022.10.274","article-title":"Activation of Nrf2 modulates protective immunity against Mycobacterium tuberculosis infection in THP1-derived macrophages","volume":"193","author":"Zhou","year":"2022","journal-title":"Free. Radic. Biol. & Med."},{"key":"10.1016\/j.biopha.2026.119708_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1379967","article-title":"The clinical relevance of heme detoxification by the macrophage heme oxygenase system","volume":"15","author":"Yeudall","year":"2024","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119708_bib50","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.4049\/jimmunol.1900553","article-title":"The BACH1-HMOX1 regulatory axis is indispensable for proper macrophage subtype specification and skeletal muscle regeneration","volume":"203","author":"Patsalos","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2026.119708_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2017.00165","article-title":"Manipulation of host cholesterol by obligate intracellular bacteria","volume":"7","author":"Samanta","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119708_bib52","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.cell.2015.11.045","article-title":"Limiting cholesterol biosynthetic flux spontaneously engages type I IFN signaling","volume":"163","author":"York","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2026.119708_bib53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.immuni.2019.11.015","article-title":"Targeting 7-dehydrocholesterol reductase integrates cholesterol metabolism and IRF3 activation to eliminate infection","volume":"52","author":"Xiao","year":"2020","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biopha.2026.119708_bib54","article-title":"Cholesterol-binding motifs in STING that control endoplasmic reticulum retention mediate anti-tumoral activity of cholesterol-lowering compounds","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biopha.2026.119708_bib55","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/14787210.2017.1305888","article-title":"Antiviral activity of cationic amphiphilic drugs","volume":"15","author":"Salata","year":"2017","journal-title":"Expert. Rev. Anti-Infect. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119708_bib56","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/glia.20906","article-title":"Involvement of cathepsin B in the processing and secretion of interleukin-1beta in chromogranin A-stimulated microglia","volume":"58","author":"Terada","year":"2010","journal-title":"Glia"},{"issue":"12","key":"10.1016\/j.biopha.2026.119708_bib57","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.4049\/jimmunol.2400322","article-title":"Nrf2 Regulates Inflammation by Modulating Dendritic Cell-T Cell Crosstalk during Viral-Bacterial Superinfection","volume":"213","author":"Duray","year":"2024","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119708_bib58","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.4049\/jimmunol.175.4.2666","article-title":"The selective estrogen receptor modulators, tamoxifen and raloxifene, impair dendritic cell differentiation and activation","volume":"175","author":"Nalbandian","year":"2005","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119708_bib59","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/jleuko\/qiad117","article-title":"Lysosomal control of dendritic cell function","volume":"114","author":"Yang","year":"2023","journal-title":"J. Leukoc. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119708_bib60","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj7293","article-title":"Nonredundancy of IL-1\u03b1 and IL-1\u03b2 is defined by distinct regulation of tissues orchestrating resistance versus tolerance to infection","volume":"8","author":"Eislmayr","year":"2022","journal-title":"Sci. Adv."},{"issue":"46","key":"10.1016\/j.biopha.2026.119708_bib61","doi-asserted-by":"crossref","first-page":"17487","DOI":"10.1074\/jbc.RA119.010149","article-title":"The transcription factor PU.1 mediates enhancer-promoter looping that is required for IL-1\u03b2 eRNA and mRNA transcription in mouse melanoma and macrophage cell lines","volume":"294","author":"Ha","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.biopha.2026.119708_bib62","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.4049\/jimmunol.1102487","article-title":"A potential suppressive effect of natural antisense IL-1\u03b2 RNA on lipopolysaccharide-induced IL-1\u03b2 expression","volume":"190","author":"Lu","year":"2013","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119708_bib63","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.4161\/auto.5.7.9820","article-title":"Tamoxifen and AEBS ligands induced apoptosis and autophagy in breast cancer cells through the stimulation of sterol accumulation","volume":"5","author":"De Medina","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2026.119708_bib64","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40478-015-0255-6","article-title":"Tamoxifen induces cellular stress in the nervous system by inhibiting cholesterol synthesis","volume":"3","author":"Denk","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.biopha.2026.119708_bib65","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1002\/cncr.11307","article-title":"Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma","volume":"97","author":"Chen","year":"2003","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2026.119708_bib66","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1248\/bpb.b17-00913","article-title":"Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures","volume":"41","author":"Yokoyama","year":"2018","journal-title":"Biol. & Pharm. Bull."},{"issue":"7","key":"10.1016\/j.biopha.2026.119708_bib67","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1158\/1078-0432.CCR-03-0538","article-title":"Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial","volume":"10","author":"Kisanga","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.biopha.2026.119708_bib68","first-page":"1629","article-title":"Concentrations of tamoxifen and its major metabolites in hormone responsive and resistant breast tumours","volume":"82","author":"MacCallum","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2026.119708_bib69","doi-asserted-by":"crossref","DOI":"10.12688\/wellcomeopenres.15010.1","article-title":"A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis","volume":"4","author":"Ngan","year":"2019","journal-title":"Wellcome Open. Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119708_bib70","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11060-015-1894-y","article-title":"A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas","volume":"125","author":"Odia","year":"2015","journal-title":"J. Neuro-Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119708_bib71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10689-015-9830-z","article-title":"Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients","volume":"15","author":"Quast","year":"2016","journal-title":"Fam. Cancer"},{"issue":"7","key":"10.1016\/j.biopha.2026.119708_bib72","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/pbc.24457","article-title":"Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children\u2019s Oncology Group (COG) phase II study","volume":"60","author":"Skapek","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"issue":"23","key":"10.1016\/j.biopha.2026.119708_bib73","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/jnci\/84.23.1811","article-title":"High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine","volume":"84","author":"Trump","year":"1992","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.biopha.2026.119708_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103942","article-title":"TRPA1 activation prompts lysosome-mediated Nrf2 degradation enhancing the killing of colorectal cancer cells","volume":"88","author":"Eskandari","year":"2025","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119708_bib75","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/2211-5463.13385","article-title":"Low-level lysosomal membrane permeabilization for limited release and sublethal functions of cathepsin proteases in the cytosol and nucleus","volume":"12","author":"Reinheckel","year":"2022","journal-title":"FEBS Open. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119708_bib76","doi-asserted-by":"crossref","DOI":"10.1172\/JCI174528","article-title":"Hemorrhage-activated NRF2 in tumor-associated macrophages drives cancer growth, invasion, and immunotherapy resistance","volume":"134","author":"Schaer","year":"2023","journal-title":"J. Clin. Investig."},{"issue":"10","key":"10.1016\/j.biopha.2026.119708_bib77","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-013063","article-title":"Stress-NRF2 response axis polarizes tumor macrophages and undermines immunotherapy","volume":"13","author":"Schaer","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2026.119708_bib78","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41590-021-00921-5","article-title":"Heme catabolism by tumor-associated macrophages controls metastasis formation","volume":"22","author":"Consonni","year":"2021","journal-title":"Nat. Immunol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:34:10Z","timestamp":1784529250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226007444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":78,"alternative-id":["S0753332226007444"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119708","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Raloxifene and tamoxifen reshape the immunometabolic phenotype of TLRs-activated macrophages through AEBS inhibition and lysosomal stress","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119708","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119708"}}